Physician profile
Peter Rosenberg
NPI 1366438228
$3,260.59
in general payments reported to CMS, 2019-2025
20 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $661 · 2020: $335 · 2021: $416 · 2022: $453 · 2023: $668 · 2024: $474 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,394.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $846.62 | 2019-2024 | Xarelto |
| Pfizer INC. | $504.59 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $342.53 | 2020-2025 | Airsupra, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $337.59 | 2019-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $293.17 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $183.20 | 2020-2024 | |
| Esperion Therapeutics, INC. | $173.85 | 2020-2025 | Nexletol |
| Allergan, INC. | $120.32 | 2019-2020 | |
| Abbvie INC. | $118.09 | 2021-2023 | Synthroid |
| Amgen INC. | $77.22 | 2022-2023 | Repatha |
| Glaxosmithkline, LLC. | $75.70 | 2023 | Shingrix, Arexvy |
| Amneal Pharmaceuticals LLC | $29.43 | 2024 | Unithroid |
| Genentech USA, INC. | $26.17 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $23.10 | 2021 | |
| Almatica Pharma LLC | $20.90 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $19.88 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.07 | 2020 | |
| Baxter Healthcare | $17.56 | 2023 | Hillrom - Connex Spot Monitor |
| Novo Nordisk INC | $16.60 | 2020 | |
| Bardy Diagnostics, INC. | $15.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rosenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.